Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults
about
Abacavir pharmacogenetics--from initial reports to standard of careAbacavir/lamivudine combination in the treatment of HIV: a review.PharmGKB summary: abacavir pathwayMultiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults.The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsInteractions between recreational drugs and antiretroviral agents.Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.Drug interactions in the management of HIV infection.Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomesAbacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.Drug interactions involving ethanol and alcoholic beverages.Drug interactions in the management of HIV infection: an update.Alcohol's role in HIV transmission and disease progression.Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine ProductsPredicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges.Abacavir-induced fulminant hepatic failure in a HIV/HCV co-infected patient.HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions.Can fomepizole be substituted by abacavir in the treatment of methanol poisoning?Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.
P2860
Q27008841-DF408DEE-C7D6-467D-A3EA-F07902A9AFCDQ33715435-D4769D12-A540-4243-9752-22A5015CD0B9Q33819062-14FB5D91-E149-4B23-878B-C62B9C8C0E0CQ33980172-A484E16A-A2CE-4762-AACD-EBEE73D84C23Q34806003-5EB2CAE9-A4E7-4199-A3BD-E629683040CBQ34874414-D0338B94-4D36-439D-A0FE-8E55932C5FB0Q35233168-4954A58E-261E-49CF-B550-313137295568Q35826691-65538847-FD88-4F6E-81A2-56DFCF3CE249Q36066083-EA5ECA6B-2B8C-4056-ADD5-7FB98E11FFB7Q36288425-960FF07F-D780-4AEE-AD53-C850EA9887E1Q36343740-CB7E5BC0-9D5B-4420-959F-E181C0A0773CQ36739802-3EF41D4C-A310-4E86-B604-97DACDE30549Q36960553-A3C0BC50-BD8F-486C-AD69-A475B3537547Q37000733-0946F70D-2F35-4A6E-A3FA-C6553B948173Q37386658-94269050-31A8-42BF-BF74-9822FFB3A21CQ38255420-4DD3AA24-220C-4CB7-BA2C-DC999BF5B5C8Q38513275-F63CEACD-CEE9-4EF8-83A2-1434651FB6D4Q38855314-7A7FD364-2F1B-4FBE-AC0B-4E6C99DB1A43Q38910835-0DD52713-2974-49F0-8EA7-830579DFF32DQ40869976-0565D051-2BF1-40A3-9B5C-CE023DE576B6Q41879018-0B1A9FC8-BACA-4F55-94AA-9A1286C0D783Q43072820-23B9DCE2-8700-4C3F-9695-758E67B178E8Q46496164-3F15CC30-AB7C-47A1-A400-235D79EC6554
P2860
Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@ast
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@en
type
label
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@ast
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@en
prefLabel
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@ast
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@en
P2093
P2860
P1476
Pharmacokinetic interaction of ...... ficiency virus-infected adults
@en
P2093
C P Stevens
G E Chittick
J A McDowell
K D Edwards
P2860
P304
P356
10.1128/AAC.44.6.1686-1690.2000
P407
P577
2000-06-01T00:00:00Z